Al Nahdi Medical Company SJSC Intrinsic Valuation and Fundamental Analysis - Al Nahdi Medical Company SJSC

Watchlist Manager

Watchlist

Price on Aug 7: 129.2 SAR

Market Cap: ﷼16.8B

Prices of SAU stocks are not being updated. The latest Al Nahdi Medical Company SJSC price on Alpha Spread is from Aug 7, 2024. Financials, forecasts and intrinsic value keep updating.

	Al Nahdi Medical Company SJSC SAU:4164	SA
E	EMKorea Co Ltd KOSDAQ:095190	KR
	Northam Platinum Holdings Ltd OTC:NPTLF	ZA
	Weimob Inc F:36W	CN
J	Japan Metropolitan Fund Investment Corp F:59JA	JP
A	Agricultural Bank of China Ltd XMUN:EK7	CN
	iEntertainment Network Inc OTC:IENT	US
S	Sompo Holdings Inc OTC:NHOLF	JP
	Marubeni Corp F:MAR0	JP
M	Marubeni Corp XMUN:MARA	JP
M	Marubeni Corp OTC:MARUY	JP
C	Canadian Natural Resources Ltd XMUN:CRC	CA

Intrinsic Value

Is Al Nahdi Medical Company SJSC undervalued or overvalued?

See the intrinsic value estimate for Al Nahdi Medical Company SJSC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

Al Nahdi Medical Company SJSC Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with Al Nahdi Medical Company SJSC’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price ﷼129.2

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Al Nahdi Medical Company SJSC Does

Retail Consumer Staples

Al Nahdi Medical Company SCJSC has entrenched itself as a prominent player within Saudi Arabia’s expansive healthcare and retail landscape. Founded in 1986, the company embarked on its journey as a single pharmacy in Jeddah, gradually evolving into the leading pharmacy retail chain in the Kingdom. This evolution is interwoven with the region’s healthcare development, echoing the burgeoning demands of a population increasingly focused on wellness and access to quality health products.

Headquarters: Saudi Arabia SA
Employees: 6 182
IPO date: Mar 22, 2022

Read the full company overview

How Al Nahdi Medical Company SJSC makes money

Al Nahdi’s business model thrives on diversification and integration within the healthcare supply chain. Core revenue streams derive from retail sales of pharmaceuticals, cosmetics, and personal care products, enhanced by a digital presence that captures the rising trend of online shopping. Their omnichannel strategy, combining physical stores with a robust e-commerce platform, presents a seamless shopping experience tailored to the modern consumer. The company also capitalizes on strategic partnerships and alliances to enhance its product offerings, ensuring that it stays ahead in the competitive landscape. Through its efficient logistics network, Al Nahdi guarantees timely delivery and product availability, which are essential to maintaining customer loyalty and market leadership. This blend of expansive reach, customer-centric service, and strategic foresight not only fuels its profitability but solidifies its position as a healthcare cornerstone across the region.

View Company Overview